Safety and efficacy of high-dose G-CSF (24 mcg/kg) for PBSC mobilisation in children

被引：0
|
作者：
Alcorta, I
Estella, J
Toll, T
Rives, S
Mateo, M
机构：
来源：
BONE MARROW TRANSPLANTATION | 2001年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S305 / S305
页数：1
相关论文
共 50 条
  • [21] Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donors
    Kröger, N
    Renges, H
    Sonnenberg, S
    Krüger, W
    Gutensohn, K
    Dielschneider, T
    Cortes-Dericks, L
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 (09) : 727 - 730
  • [22] Stem cell mobilisation with 16 μg/kg vs 10 μg/kg of G-CSF for allogeneic transplantation in healthy donors
    N Kröger
    H Renges
    S Sonnenberg
    W Krüger
    K Gutensohn
    T Dielschneider
    L Cortes-Dericks
    AR Zander
    Bone Marrow Transplantation, 2002, 29 : 727 - 730
  • [23] High dose etoposide phosphate and G-CSF as an effective second line PBSC mobilization regimen
    Dwilewicz-Trojaczek, J
    Torosian, T
    Rokicka, M
    Sachs, W
    Madry, K
    Nowicka, U
    Pol, E
    Król, M
    Wiktor-Jedrzejczak, W
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 25 - 28
  • [24] G-CSF PRIMED PERIPHERAL STEM-CELL (PPSC) AUTOGRAFTS IN PATIENTS (PTS) WITH ADVANCED LYMPHOMA - COMPARISON BETWEEN G-CSF DOSE OF 5 AND 10 MCG/KG/DAY
    NADEMANEE, A
    SNIECINSKI, I
    SCHMIDT, GM
    WOO, D
    SNYDER, DS
    ODONNELL, MR
    PARKER, PM
    STEIN, A
    SMITH, E
    MOLINA, A
    WONG, KK
    STEPAN, DE
    MARGOLIN, KA
    SOMLO, G
    DAGIS, AC
    NILAND, JC
    FORMAN, SJ
    BLOOD, 1993, 82 (10) : A638 - A638
  • [25] Intermediate VP-16 (1gr/m2) plus G-CSF (10mcg/kg) or cyclophosphamide (3gr/m2) plus G-CSF (10mcg/kg) for progenitor cell mobilisation in lymphoma patients
    Pivkova, A.
    Stavrik, S. Genadieva
    Stojanoski, Z.
    Cevreska, L.
    Karanfilski, O.
    Milenkov, V.
    Georgievski, B.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S212 - S212
  • [26] COMPARISON OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF WITH G-CSF ALONE FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN MM
    Jang, J. E.
    Hyun, S. Y.
    Hwang, D. Y.
    Yoon, S. H.
    Kim, Y. D.
    Kim, S. J.
    Kim, J. S.
    Cheong, J. -W.
    Min, Y. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
  • [27] Use of KGF (palifermin) but not of G-CSF is associated o a reduced rate of infections after high-dose chemotherapy and autologous PBSC transplantation
    Milone, G.
    Battiato, K.
    Murgano, P.
    Coppoletta, S.
    Mauro, E.
    Spadaro, A.
    Poidomani, M.
    Di Marco, A.
    Leotta, S.
    Oliva, E.
    Giustolisi, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S272 - S272
  • [28] Comparable efficacy and safety of biosimilar and originator G-CSF in patients undergoing haematopoietic stem cell mobilisation
    Dmoszynska, A.
    Manko, J.
    Croneck, A.
    Grzasko, N.
    Klimek, P.
    Nowaczynska, A.
    Gorska-Kosicka, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S231 - S232
  • [29] Low dose Ctx and G-CSF as a mobilising regimen for autologous PBSC harvesting
    Deliliers, GL
    Annaloro, C
    Marconi, M
    Tagliaferri, E
    Luchesini, C
    Luminari, S
    Della Volpe, A
    BONE MARROW TRANSPLANTATION, 2001, 27 : S167 - S167
  • [30] A randomised study of 10 μg/kg/day (single dose) vs 2 × 5 μg/kg/day (split dose) G-CSF as stem cell mobilisation regimen in high-risk breast cancer patients
    R Carrión
    D Serrano
    A Gómez-Pineda
    J L Díez-Martín
    Bone Marrow Transplantation, 2003, 32 : 563 - 567
12345